Background. The role of GPs in recruiting or excluding participants critically underpins the feasibility, external validity and generalizability of primary care research. A better understanding of this role is needed. Aim. To investigate why GPs excluded potentially eligible participants from a large scale randomized controlled trial (RCT), to determine the proportion of patients excluded on account of trial eligibility compared with other reasons, and to explore the impact of such exclusions on the management and generalizability of RCTs. Design and setting. Secondary analysis of data from the CoBalT study, a multi-centre generalpractice-based RCT investigating cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression. Method. GPs were asked to screen patient lists generated from computerized record searches for trial eligibility and to provide narrative reasons for excluding patients. These reasons were coded independently by two researchers, with a third researcher resolving discrepancies. Results. Thirty-one percent (4750/15 379) of patients were excluded at the GP screening stage, including 663 on patient lists that remained unscreened. Of the 4087 actively excluded patients, 67% were excluded on account of trial exclusion criteria, 20% for other criteria (half of which were comorbid conditions) and 13% without reason. Conclusion. Clear, comprehensive criteria, particularly with regards to comorbidities, are required for GPs to confidently screen patients for potential participation in research. Future studies should promote inclusivity and encourage GPs to adopt a liberal approach when screening patient lists. This would enhance the validity and generalizability of primary care research and encourage greater patient autonomy.
Introduction
Funding bodies award substantial resources to support medical and applied health research, and randomized controlled trials (RCTs) are the gold standard used to determine the effectiveness of an intervention. To ensure generalizability of trial findings, research participants should reflect the population they represent. Therefore, in primary care research, GPs have a critical role in recruiting potential participants by directly approaching patients and/or screening patient lists for trial eligibility (1) .
Recruitment is rarely straightforward; GPs may face difficult decisions and ethical dilemmas when inviting patients to participate in a trial, irrespective of eligibility criteria. For example, GPs may adopt a protective role by viewing the research process as an unnecessary burden to patients and practice staff (2, 3) or deem some patients unsuitable (4, 5) , which may be the case for patients with life-threatening comorbidities (6, 7) . Some GPs may underestimate patients' desire to participate in research (8, 9) or not appreciate the benefit patients may experience, even when in the control arm of a trial (10, 11) . Furthermore, a practice might agree to participate in a trial but variation in enthusiasm among GPs may negatively affect patient recruitment (1, 12) . GPs often screen lists containing patients with whom they are not familiar, which can lead to patients being excluded who may have been included (or vice versa) if an acquainted GP had screened the list (5) . One suggestion is that GPs inform all eligible patients of research opportunities and support their patients' decisions regarding participation (8) .
This recruitment stage greatly influences the external validity of a trial, particularly if eligible patients are not recruited (13) , if eligibility criteria result in randomized participants not representing the majority of patients seen in clinical practice (13) (14) (15) , or if the process between identifying potential participants and randomization is not explicitly reported (13) . In a recent review of RCTs, the eligibility fraction (proportion of screened potential participants who meet the trial eligibility criteria) was only reported in 80% of trials and although the median eligibility fraction was 83%, it fell <40% in a quarter of the reviewed trials (13) .
The CoBalT trial
This large multi-centre RCT investigated cognitive behavioural therapy (CBT) as an adjunct to pharmacotherapy for patients with treatment-resistant depression in primary care (16) . GPs in Bristol, Exeter and Glasgow were invited to take part by identifying and inviting potentially eligible patients for the study. GPs were asked to provide reasons for any patient they excluded. Searches of practice computerized medical records and direct GP referrals yielded 15 416 potentially eligible patients. Of the 15 379 patients identified through record searches, 4750 (31%) were subsequently excluded by GPs (17) . The aims of this secondary analysis were to investigate why patients were excluded by GPs, to determine the proportion of patients excluded on account of trial eligibility criteria compared with other reasons and to explore the potential impact of such exclusions on the management and generalisability of RCTs in general.
Method
The primary care research network (PCRN) for England and the Scottish PCRN facilitated the invitation of practices to participate in the CoBalT study. Of the 106 practices approached, 88 practices expressed an interest in the study and were subsequently visited and briefed by members of the research team. Patients were recruited from 73 practices between November 2008 and September 2010 (16) . Recruitment did not take place at the remaining 15 practices due to other practice priorities at the proposed time of recruitment. Recruitment of patients predominantly involved searches of practice computerized medical records to identify potentially eligible participants who were aged 18-75 years and had received repeated prescriptions for anti-depressant medication at an adequate dose for depression (17) . GPs were asked to screen patient lists for eligibility within two weeks of the index search using the trial exclusion criteria and to provide narrative reasons for patients they excluded. The trial exclusion criteria barred patients who (i) were not aged 18-75 years, (ii) had not been taking anti-depressant medication for at least 6 weeks, (iii) had bipolar disorder or psychosis, (iv) had major alcohol or substance abuse problems, (v) were unable to complete the study questionnaires, (vi) were currently being treated in secondary care for depression, (vii) were currently receiving or had received CBT in the last 3 years, or (viii) were pregnant. GPs could also exclude patients for whom they felt the trial would be inappropriate. By providing narrative reasons, both the effective use of the trial eligibility criteria and the nature of any additional criteria that were applied by GPs could be explored.
GPs' narrative reasons were entered verbatim onto the CoBalT database. The reasons consisted of between 1 and 10 words, though most consisted of less than five words (e.g. 'secondary care', 'psychosis'). Preliminary coding of these reasons was conducted independently by two researchers (HS and RW) on 200 cases to develop a coding framework, by which time data saturation had been reached. Reasons beyond the trial exclusion criteria [as per (i) to (viii) listed above] were classified into 16 additional criteria created through identification of recurring themes in the data. Due to the brevity of GPs' reasons and the quantification of data, all coding was conducted using content analysis (18) . A third researcher (CJ) checked and resolved any discrepancies. For simplicity, these additional reasons provided by GPs for excluding patients for whom they thought the trial was inappropriate will be referred to as 'other criteria'. When coding GPs' narratives, the researchers made the assumption that if a specific condition other than depression was included, for example, 'anxiety', 'multiple sclerosis' or 'cancer', the reason was coded as a 'comorbid condition'. (Terminal illnesses were coded separately and due to the very small number, were grouped in the 'miscellaneous other reason'.) Some reasons were too vague, for example, 'in hospital' or 'too unwell' and were coded under 'reason unclear or unspecific'. Unusual reasons such as 'runs a pub', 'too busy' and 'odd' were coded under 'miscellaneous other reason'.
Data analyses
Data was analysed in PASW version 18 (IBM Corporation, 2011). For each patient, both the number and category of reasons given by the GP were identified. To determine the proportion of patients excluded on account of trial exclusion criteria, where GPs had given more than one reason for excluding an individual, trial exclusion criteria were prioritized as the main reason for exclusion. The relative frequency for each criterion was described and the variation in these relative frequencies between trial sites was explored. For the more commonly occurring categories of reasons, between site differences were compared using chi-square tests. In light of multiple testing, a Bonferroni correction was applied and P < 0.002 was used as the significance threshold.
Results
A summary of the initial stages of recruitment are shown in Table 1 . Of the 15 379 patients identified by record searches, 4% of patients (n = 663) were excluded regardless of eligibility because patient lists remained unscreened by GPs. Closer inspection of data (not shown here) revealed that sections of patient lists from 11 practices were unscreened by GPs. Data analysis focuses on the 4087 patients who were actively excluded by GPs. Table 2 summarizes the numbers of patients excluded according to trial exclusion, other criteria or without reason across trial sites. GPs provided a single reason to exclude 82% of patients (n = 3362) and multiple reasons to exclude 5% of patients (n = 184) ( Table 3 ). However, 541 (13%) patients were excluded without a reason being recorded, representing 4% of the total number of patients identified by record searches. A detailed summary of trial exclusion criteria and other criteria provided by GPs is shown in Table 4 . Ten percent (n = 391) of patients were excluded for having a comorbid condition; anxiety (n = 51) was most common, followed by neuroses (e.g. obsessive-compulsive disorder, phobia; n = 47) and personality disorders (n = 31). Statistically significant differences in the frequencies of reasons for exclusion between trial sites were found (Table 4 ) and developed (Table 5 ). Differences were substantial regarding alcohol or substance abuse and comorbidity being more commonly reported in practices recruited in Bristol and Glasgow. In Glasgow, a higher proportion of patients were excluded because they were currently receiving secondary care for their depression, while Bristol GPs excluded a greater proportion of patients because of specified comorbid conditions.
Discussion

Summary
This study aimed to gain a better understanding of GPs' reasons for excluding patients and the impact of such exclusions on RCTs, using data previously collected during the CoBalT trial.
Of the patients identified from searches of practice computerized records, two-thirds were actively excluded by GPs on account of trial exclusion criteria and a fifth was excluded due to other criteria. Within the other criteria, half of patients were excluded because of comorbid conditions, thus highlighting the need for GPs to acknowledge that patients with comorbidities are eligible and should not be excluded unless specifically stated in the trial eligibility criteria. The remaining other criteria given by GPs were considered justifiable from The proportion of excluded patients for whom the GP gave this reason differed significantly between trial sites (chi-square test, P < 0.002). the narrative descriptions provided. However, a quarter of all excluded patients were either never considered for the trial due to sections of patient lists remaining unscreened, or were actively excluded by GPs without reason. These two unknown factors have the potential to affect external validity and generalizability of trial findings. In this trial, these exclusions each accounted for 4% (n = 663 and n = 541, respectively) of the 15 379 potentially eligible patients identified from searches of computerized patient records. Conversely, some GPs provided multiple reasons for excluding patients; if a patient fails to meet any trial eligibility criteria, they are automatically excluded. Perhaps some GPs provided multiple reasons to justify excluding patients on account of other criteria. Across sites, there were noticeable differences in the numbers of both GP practices who did not screen entire patient lists, and patients actively excluded by GPs without reason. Unlike practices in Bristol and Exeter, those in Glasgow screened every patient. One explanation may be that another large depression trial (19) concurrently conducted in Bristol and Exeter meant individual GPs were busy with other research commitments (or simply chose not) to screen their portion of the patient lists within the given timeframe. Closer inspection of data (not presented here) revealed that entire patient lists, or a large proportion of patients thereof, were more likely to be excluded without reason as opposed to a few individual patients within a list. Again, it is feasible that individual GPs within a practice were unavailable to screen their section of the patient list so either they, or their fellow GPs excluded patients without reason to return the patient list on time.
Other differences may be explained by the socioeconomic profile of the population residing in the areas surrounding the trial sites. Glasgow and Bristol are large cities populated with higher proportions of people at lower socioeconomic levels than Exeter, a smaller city surrounded by rural areas, with a less transient population (20, 21) . Therefore, it is not unexpected that more patients were excluded due to alcohol or substance abuse in Bristol and Glasgow. However, site differences in the number of patients receiving secondary care for depression or having comorbidities are less easy to explain.
Strengths and limitations
CoBalT was a large, successful RCT with 90% of randomized participants followed up at 6 months and 84% at 12 months (16). The trial is data rich; few RCTs explore why patients decline participation (22) or report an intensive and careful review of GPs' reasons for excluding patients during the screening stage of recruitment.
Although the data is incomplete insomuch as GPs excluded 541 patients without reason, and 663 patients remained unscreened and therefore never considered for the trial; these facts are informative about what happens during an RCT. However, it is difficult to know how this missing data might have affected the figures presented. Furthermore, the generalizability of our findings may not extend to trials unrelated to mental illhealth because GPs may not only view depressed patients as more vulnerable and in need of protection but may also perceive their consultations with depressed patients to be more difficult compared with patients with other conditions (2) . However, the proportion of patients who remained unscreened may simply reflect GPs' lack of time and could therefore be similar across all primary care trials, regardless of the illness being treated.
Comparisons with existing literature
Of the original 15 379 patients identified from searches of computerized patient records, 4% of patients were not screened by GPs and 4% of patients were excluded without the GP giving a reason. Lack of time (3, 23, 24) , forgetfulness (23, 24) , or a belief that the intervention was not the best treatment for a patient may be why GPs excluded these patients (24) . Given that recruitment targets are based on power calculations (25) , once a practice agrees to participate in a trial, researchers should make every effort to encourage GPs to screen patient lists. By agreeing to take part in the trial, a GP practice is acknowledging not only that the best treatment option for their patients is unknown, but the research intervention may or may not be a better treatment than those currently available (26) . With clinical equipoise in mind, the practice is still happy to invest their staff time in the recruitment process. Therefore, it may be morally questionable not only in respect of the staff who spend time generating patient lists that remain unscreened, but also of the patients who are denied both the opportunity to participate in research, and the positive aspects that participants describe from taking part [regardless of being on the intervention or control arm] (10,11). Two-thirds of those patients screened by GPs were excluded (appropriately) by trial exclusion criteria. The other criteria given by GPs for excluding potential participants seemed mostly justifiable, for example, patients who were not depressed, had recovered from depression or were doing well on medication, were participating in other research, had declined research participation, had changed address, were working away or had died. However, the GPs' advocacy role, and the notion that participating in research may be an unnecessary burden to patients (2, 8) were highlighted by reasons such as patients would not cope, had mobility issues, or were complex cases. These criteria accounted for 4% of excluded patients. Furthermore, 10% of patients were excluded due to their comorbid conditions. Given that multimorbidity is common, even in younger age groups (27) , and that people with chronic illnesses are three to four times more likely to have depression than the general population (28) , it may be useful to include such individuals in research to increase the external validity and generalizability of results (6, 7, 29) . Life-threatening comorbidities aside, by adopting a more inclusive approach, patients would be given the chance to make their own decision about whether they could cope or wish to participate in a trial.
Implications for research and practice
In this study, one-third of patients excluded by GPs were excluded either for reasons beyond the trial exclusion criteria, or for an unknown reason. This leads to the question of whether the trial exclusion criteria were sufficiently comprehensive or, conversely, whether the GPs were being overprotective of their patients. The presence of a comorbid condition was most commonly given as a reason for excluding a patient by GPs despite only a limited number of conditions being listed in the trial exclusion criteria. Therefore, given the prevalence of depression among people with chronic illnesses, it may be prudent to provide detailed and specific guidance to GPs for screening patients with comorbid conditions: unless a specific condition is listed in the trial exclusion criteria, patients with comorbidities should be included. Furthermore, to enhance trial recruitment in primary care, transparent rationale supporting the trial and eligibility criteria should be simply stated so GPs can quickly and confidently include or exclude patients without jeopardizing patient care or the external validity of the trial. Robust exclusion criteria and clearer, well-defined guidelines on how to categorize patients into those exclusion criteria will remove the onus of excluding potentially eligible patients from GPs and reduce the time GPs spend on deliberating over whether a patient should be included into a research study. These guidelines may be honed by a feasibility study early on in the trial recruitment process. Furthermore, GPs should be reminded of the different screening stages where patients may be excluded during the recruitment process, and that patients can withdraw from the study at any time, without reason and without patients worrying that their medical care may be affected. The benefits to patients of participating in research (10, 11) should be emphasized. Finally, there may be a case for simply reiterating that a study has been ethically approved and includes a rigorous informed consent procedure which by its very nature empowers the patient with the ultimate choice of whether or not to participate in the trial.
